Real-world performance of SARS-Cov-2 serology tests in the United States, 2020 is a research paper published in PLOS ONE (2023). On theSindex it has a DataRank of 0.165. It has been cited 2 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Rockefeller Foundation
Grant: HTH 030 GA-S
Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation
Grant: 3U01FD005938
FDA, UCSF-Stanford Center of Excellence in Regulatory Sciences and Innovation
Grant: award number A128219 and Grant Number U01FD005978
FDA HHS
Grant: U01 FD005938
FDA HHS
Grant: U01 FD005978
FDA HHS
Grant: U01 FD007223
FWCI
0.50
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals